Matches in Wikidata for { <http://www.wikidata.org/entity/Q53841494> ?p ?o ?g. }
- Q53841494 description "2018 nî lūn-bûn" @default.
- Q53841494 description "2018年の論文" @default.
- Q53841494 description "2018年学术文章" @default.
- Q53841494 description "2018年学术文章" @default.
- Q53841494 description "2018年学术文章" @default.
- Q53841494 description "2018年学术文章" @default.
- Q53841494 description "2018年学术文章" @default.
- Q53841494 description "2018年學術文章" @default.
- Q53841494 description "2018年學術文章" @default.
- Q53841494 description "2018年學術文章" @default.
- Q53841494 description "2018年學術文章" @default.
- Q53841494 description "2018年學術文章" @default.
- Q53841494 description "2018年學術文章" @default.
- Q53841494 description "2018년 논문" @default.
- Q53841494 description "article científic" @default.
- Q53841494 description "article scientific" @default.
- Q53841494 description "article scientifique (publié 2018)" @default.
- Q53841494 description "articol științific" @default.
- Q53841494 description "articolo scientifico" @default.
- Q53841494 description "artigo científico (publicado na 2018)" @default.
- Q53841494 description "artigo científico (publicado na 2018)" @default.
- Q53841494 description "artigo científico" @default.
- Q53841494 description "artikull shkencor" @default.
- Q53841494 description "artikulong pang-agham" @default.
- Q53841494 description "artykuł naukowy" @default.
- Q53841494 description "artículo científico publicado en 2018" @default.
- Q53841494 description "artículu científicu" @default.
- Q53841494 description "bilimsel makale" @default.
- Q53841494 description "bài báo khoa học" @default.
- Q53841494 description "mokslinis straipsnis" @default.
- Q53841494 description "naučni članak" @default.
- Q53841494 description "scienca artikolo" @default.
- Q53841494 description "scientific article" @default.
- Q53841494 description "teaduslik artikkel" @default.
- Q53841494 description "tieteellinen artikkeli" @default.
- Q53841494 description "tudományos cikk" @default.
- Q53841494 description "vedecký článok" @default.
- Q53841494 description "vetenskaplig artikel" @default.
- Q53841494 description "videnskabelig artikel (udgivet 2018)" @default.
- Q53841494 description "vitenskapelig artikkel" @default.
- Q53841494 description "vitskapeleg artikkel" @default.
- Q53841494 description "vědecký článek" @default.
- Q53841494 description "wetenschappelijk artikel" @default.
- Q53841494 description "wissenschaftlicher Artikel" @default.
- Q53841494 description "επιστημονικό άρθρο" @default.
- Q53841494 description "мақолаи илмӣ" @default.
- Q53841494 description "мақолаи илмӣ" @default.
- Q53841494 description "наукова стаття, опублікована в лютому 2018" @default.
- Q53841494 description "научна статия" @default.
- Q53841494 description "научная статья" @default.
- Q53841494 description "научни чланак" @default.
- Q53841494 description "научни чланак" @default.
- Q53841494 description "գիտական հոդված" @default.
- Q53841494 description "מאמר מדעי" @default.
- Q53841494 description "سائنسی مضمون" @default.
- Q53841494 description "مقالة علمية" @default.
- Q53841494 description "مقالهٔ علمی" @default.
- Q53841494 description "২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q53841494 description "บทความทางวิทยาศาสตร์" @default.
- Q53841494 description "სამეცნიერო სტატია" @default.
- Q53841494 name "A Phase 1 Study to Evaluate the Effect of Crushing, Cutting Into Half, or Grinding of Glecaprevir/Pibrentasvir Tablets on Exposures in Healthy Subjects." @default.
- Q53841494 name "A Phase 1 Study to Evaluate the Effect of Crushing, Cutting Into Half, or Grinding of Glecaprevir/Pibrentasvir Tablets on Exposures in Healthy Subjects." @default.
- Q53841494 type Item @default.
- Q53841494 label "A Phase 1 Study to Evaluate the Effect of Crushing, Cutting Into Half, or Grinding of Glecaprevir/Pibrentasvir Tablets on Exposures in Healthy Subjects." @default.
- Q53841494 label "A Phase 1 Study to Evaluate the Effect of Crushing, Cutting Into Half, or Grinding of Glecaprevir/Pibrentasvir Tablets on Exposures in Healthy Subjects." @default.
- Q53841494 prefLabel "A Phase 1 Study to Evaluate the Effect of Crushing, Cutting Into Half, or Grinding of Glecaprevir/Pibrentasvir Tablets on Exposures in Healthy Subjects." @default.
- Q53841494 prefLabel "A Phase 1 Study to Evaluate the Effect of Crushing, Cutting Into Half, or Grinding of Glecaprevir/Pibrentasvir Tablets on Exposures in Healthy Subjects." @default.
- Q53841494 P1433 Q53841494-68E0C200-A00D-4FD0-95E9-8B89445C3489 @default.
- Q53841494 P1476 Q53841494-45B75479-7308-4B12-8A87-74C15439E4D9 @default.
- Q53841494 P2093 Q53841494-0A77EBD7-E883-441E-9FB4-2EA0782FB4F6 @default.
- Q53841494 P2093 Q53841494-59165F48-9554-4072-9C9D-343BDD4F695E @default.
- Q53841494 P2093 Q53841494-6E7BE45D-E67E-4B7D-A28E-69419FC97044 @default.
- Q53841494 P2093 Q53841494-ACB8E668-5E6B-4E45-A340-BD4AE03D8DF2 @default.
- Q53841494 P2093 Q53841494-EA4DEDAE-4938-43C9-8ECC-3C27F45D9680 @default.
- Q53841494 P2093 Q53841494-EF93E94C-F1E0-4E6E-9013-0623DEC0F262 @default.
- Q53841494 P2860 Q53841494-007DF6E4-FDCD-4BA8-97BD-414A5562F797 @default.
- Q53841494 P2860 Q53841494-12575C58-4473-4378-AFFE-ED215236851A @default.
- Q53841494 P2860 Q53841494-1AA678C5-ACAD-4A1C-B19E-9F6C1D264446 @default.
- Q53841494 P2860 Q53841494-48353CB7-74E4-4FE2-B7CD-2CB6A683D540 @default.
- Q53841494 P2860 Q53841494-50420D45-D31E-4B53-A83D-DB8E9BA5E7D2 @default.
- Q53841494 P2860 Q53841494-60936F65-1850-47C6-A890-4CDCDBCA243F @default.
- Q53841494 P2860 Q53841494-6344877A-568E-41CC-80FE-AA5BFC6F0E1D @default.
- Q53841494 P2860 Q53841494-6FA01D99-9BB5-496E-BB74-15BA37F741E4 @default.
- Q53841494 P2860 Q53841494-83A022D7-DA73-4AF8-A131-711FDEDB7FDC @default.
- Q53841494 P2860 Q53841494-947F241F-37DB-40AD-A957-0193A9831780 @default.
- Q53841494 P2860 Q53841494-9D7D5103-D162-4790-81DF-CDB5C8314DC5 @default.
- Q53841494 P2860 Q53841494-D65F116B-7F55-4483-BE23-D6DBF123833D @default.
- Q53841494 P2860 Q53841494-F75E5136-C736-4D59-A7C3-9E73057721F5 @default.
- Q53841494 P31 Q53841494-B456198B-82E1-4581-B560-16D05E72A021 @default.
- Q53841494 P356 Q53841494-8CA39051-593D-4726-A1E6-9C3CE00F80A3 @default.
- Q53841494 P407 Q53841494-E1FA5564-04F4-41ED-8BCB-C5277B39ECA8 @default.
- Q53841494 P577 Q53841494-30A6482A-24FE-4BC9-9A26-7262A662B5FD @default.
- Q53841494 P698 Q53841494-598BD985-0A99-4D4B-B9D3-187D2039EC5B @default.
- Q53841494 P356 J.XPHS.2018.02.015 @default.
- Q53841494 P698 29476763 @default.
- Q53841494 P1433 Q3186933 @default.
- Q53841494 P1476 "A Phase 1 Study to Evaluate the Effect of Crushing, Cutting Into Half, or Grinding of Glecaprevir/Pibrentasvir Tablets on Exposures in Healthy Subjects." @default.
- Q53841494 P2093 "Dilraj S Sidhu" @default.
- Q53841494 P2093 "Rajneet K Oberoi" @default.
- Q53841494 P2093 "Roger Trinh" @default.